Paper68962
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N and 3 others. J Clin Invest, 1977. Cited by 159 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The behavior of alpha2-plasmin inhibitor in fibrinolytic states. Papers, record 68962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68962
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alpha-Globulins | Major topic |
| Fibrinolysin | Major topic |
| Fibrinolysis | Major topic |
| Fibrinogen | |
| Humans | |
| Immunoelectrophoresis | |
| Kinetics | |
| Plasminogen | |
| Plasminogen Activators | |
| Plasminogen Inactivators | |
| Urokinase-Type Plasminogen Activator |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,080,301 | Immunochemical distinction between antiplasmin and alpha-antitrypsin. | Thromb Res | 1975 | https://conductscience.org/library/papers/1080301 | PubMed |
| 2 | 127,607 | Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum. | Br J Haematol | 1975 | https://conductscience.org/library/papers/127607 | PubMed |
| 3 | 131,986 | Inhibition of plasmin by normal and antiplasmin-depleted human plasma. | Thromb Res | 1976 | https://conductscience.org/library/papers/131986 | PubMed |
| 4 | 134,465 | Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma. | Thromb Res | 1976 | https://conductscience.org/library/papers/134465 | PubMed |
| 5 | 134,998 | Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. | J Biol Chem | 1976 | https://conductscience.org/library/papers/134998 | PubMed |
| 6 | 13,664,784 | The mechanism of clot dissolution by plasmin. | J Clin Invest | 1959 | https://conductscience.org/library/papers/13664784 | PubMed |
| 7 | 14,081,261 | THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY. | Thromb Diath Haemorrh | 1963 | https://conductscience.org/library/papers/14081261 | PubMed |
| 8 | 14,097,352 | THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. | Biochem J | 1963 | https://conductscience.org/library/papers/14097352 | PubMed |
| 9 | 14,253,483 | A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD. | J Exp Med | 1965 | https://conductscience.org/library/papers/14253483 | PubMed |
| 10 | 14,302,464 | ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. | Anal Biochem | 1965 | https://conductscience.org/library/papers/14302464 | PubMed |
| 13 | 4,114,014 | 2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. | Scand J Clin Lab Invest | 1972 | https://conductscience.org/library/papers/4114014 | PubMed |
| 14 | 4,114,358 | Electroimmuno assay. | Scand J Clin Lab Invest Suppl | 1972 | https://conductscience.org/library/papers/4114358 | PubMed |
| 15 | 4,237,416 | Molecular weight studies on human plasminogen and plasmin at the microgram level. | J Biol Chem | 1969 | https://conductscience.org/library/papers/4237416 | PubMed |
| 16 | 4,249,466 | The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state. | Thromb Diath Haemorrh | 1970 | https://conductscience.org/library/papers/4249466 | PubMed |
| 17 | 4,251,631 | Human serum plasminogen antiactivator: its distinction from antiplasmin. | Am J Physiol | 1971 | https://conductscience.org/library/papers/4251631 | PubMed |
| 18 | 4,251,763 | Plasminogen-plasmin system. VI. Preparation of alpha 2-macroglobulin antiplasmin from human plasma. | Biochim Biophys Acta | 1970 | https://conductscience.org/library/papers/4251763 | PubMed |
| 19 | 4,275,737 | Distinction of serum inhibitor of activator-induced clot lysis from alpha1-antitrypsin. | Proc Soc Exp Biol Med | 1974 | https://conductscience.org/library/papers/4275737 | PubMed |
| 20 | 4,276,455 | The inhibition of human plasmin by human antithrombin-heparin cofactor. | J Biol Chem | 1974 | https://conductscience.org/library/papers/4276455 | PubMed |
| 21 | 4,282,470 | Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. | Biochem J | 1974 | https://conductscience.org/library/papers/4282470 | PubMed |
| 22 | 4,543,991 | Studies on an inhibitor of plasminogen activation in human serum. | Thromb Diath Haemorrh | 1973 | https://conductscience.org/library/papers/4543991 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,504,559 | Use of Affimer technology for inhibition of α2-antiplasmin and enhancement of fibrinolysis. | Blood Adv | 2025 | https://conductscience.org/library/papers/39504559 | PubMed |
| 38,395,065 | Fibrinolysis-Mediated Pathways in Acute Liver Injury. | Semin Thromb Hemost | 2024 | https://conductscience.org/library/papers/38395065 | PubMed |
| 34,406,905 | Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation. | Am J Physiol Cell Physiol | 2021 | https://conductscience.org/library/papers/34406905 | PubMed |
| 27,472,428 | α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke. | Semin Thromb Hemost | 2017 | https://conductscience.org/library/papers/27472428 | PubMed |
| 18,674,818 | Biological activities of C1 inhibitor. | Mol Immunol | 2008 | https://conductscience.org/library/papers/18674818 | PubMed |
| 7,199,538 | Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199538 | PubMed |
| 6,786,463 | Acquired alpha 2 antiplasmin deficiency in glomerular proteinuria. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6786463 | PubMed |
| 6,444,305 | Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6444305 | PubMed |
| 6,388,669 | Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli. | Blut | 1984 | https://conductscience.org/library/papers/6388669 | PubMed |
| 6,166,634 | Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6166634 | PubMed |
| 3,166,140 | Organization of the human alpha 2-plasmin inhibitor gene. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3166140 | PubMed |
| 3,038,753 | Identification of a specific receptor for plasmin on a group A streptococcus. | Infect Immun | 1987 | https://conductscience.org/library/papers/3038753 | PubMed |
| 2,526,671 | Clinical disorders of fibrinolysis: a critical review. | Blut | 1989 | https://conductscience.org/library/papers/2526671 | PubMed |
| 2,496,145 | Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2496145 | PubMed |
| 2,419,360 | Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. | J Clin Invest | 1986 | https://conductscience.org/library/papers/2419360 | PubMed |
| 659,588 | Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. | J Clin Invest | 1978 | https://conductscience.org/library/papers/659588 | PubMed |
| 156,364 | Inhibitory spectrum of alpha 2-plasmin inhibitor. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/156364 | PubMed |
| 156,196 | Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. | J Clin Invest | 1979 | https://conductscience.org/library/papers/156196 | PubMed |
| 151,804 | The human plasma fibrinolytic system: regulation and control. | Mol Cell Biochem | 1978 | https://conductscience.org/library/papers/151804 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| A2M | 2 | PubTator's text mining | https://conductscience.org/library/genes/2 | NCBI Gene |
| PLAU | 5,328 | PubTator's text mining | https://conductscience.org/library/genes/5328 | NCBI Gene |
| PLG | 5,340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINA1 | 5,265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
| SERPINF2 | 5,345 | PubTator's text mining | https://conductscience.org/library/genes/5345 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68962
GET https://conductscience.org/api/papers/v1/68962/references?page=2